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ABSTRACT 
 
Background: Increasing the duration of action and maximizing postoperative analgesia 
has always been a domain of interest in spinal blocks. Many adjuvants have been tried 
along with local anaesthetic agent to achieve the same. The following study was 
conducted to compare sensory and motor characteristics with 2mg midazolam in 
subarachnoid block. Aim: To evaluate the efficacy and analgesic effect of the mixture 
of 2 mg midazolam and 15 mg (3 ml) hyperbaric bupivacaine as compared to 
bupivacaine alone in patients undergoing infra-umbilical surgery under spinal block.  
Material and Methods: In this observational prospective case control study 100 
patients (ASA class I and II), aged 18 to 55 years, undergoing elective infra -umbilical 
surgeries under spinal block were randomly divided into Group I- patients were 
administered 0.5% hyperbaric Bupivacaine (3 ml) + 0.9% Normal saline (0.4 ml) 
intrathecally and Group 2- patients were administered 0.5% hyperbaric Bupivacaine (3 
ml) + 2mg preservative free Midazolam (0.4 ml) intrathecally. The onset and duration 
of sensory and motor block, hemodynamic variables, and side effects during the 
surgery and recovery were compared among the groups. Results: 2mg of preservative 
free midazolam used as an adjuvant to bupivacaine intrathecally reduces onset time of 
sensory and motor blockade, also time taken to reach T-10. It also increases time taken 
for two segmental recession and mean duration of analgesia . Conclusion: It can be 
inferred that Inj. Midazolam 2 mg in combination with Inj. bupivacaine   0.5%   
hyperbaric   can   be   safely   administered   intrathecally for   better postoperative 
analgesia. 
KEYWORDS: Intrathecal Midazolam, Post-operative Analgesia, Bupivacaine, Spinal 
Anesthesia. 
INTRODUCTION 
Regional anaesthesia, for below umbilical surgeries, is held 
generally to be safer than general anaesthesia. Regional 
anaesthesia avoids general anaesthesia related problems. 
General anaesthesia may pose problems like poly-pharmacy, 
airway  manipulation,   misplacement  of  endotracheal  tube,   
hypo  or   hyper ventilation,  vomiting,  pulmonary  aspiration. 
Regional anaesthesia attenuates increase in plasma 
catecholamine and other hormones by reducing surgical 
stress.  Regional anaesthesia gives intra and postoperative 
pain relief and at the same time preserves mental status and 
normal reflexes. For below umbilical surgeries, the 
subarachnoid blockade being the common form of neuraxial 
blockade performed, it ensures the patient wellbeing and 
facil itates the surgeon's work. Commonly used drug is 0.5% 
hyperbaric bupivacaine which produces longer duration of 
anaesthesia along with good muscle relaxation and effective 
pain relief in initial post-operative period.  
Increasing the duration of action and maximizing 
postoperative analgesia has always been a domain of interest 
in subarachnoid blocks. Many adjuvants have been tried along 
with local anesthetic agent to achieve the same. Intrathecal 
opioids provide good postoperative analgesia but are 
associated with adverse effects of itching, nausea, urinary 
retention, sedation, i leus and life-threatening respiratory 
depression [1]. Other adjuvants l ike clonidine, neostigmine and 
ketamine have been tried but are not used in routine clinical 
practice owing to their adverse effects [2,3,4]. Midazolam 
potentiates the effect of local anaesthetics improving the 
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quality of sensory and motor blockade, also increases the 
duration of post-operative analgesia without causing side 
effects of bradycardia, hypotension, post-operative nausea-
vomiting, pruritus, urinary retention, sedation and 
neurotoxicity [5-11]. Considering only a l imited number of 
studies assessing the efficacy of intrathecal midazolam 
combined with bupivacaine in humans [12,13], following study 
was conducted to compare sensory and motor  characteristics 
between 3.0mL of 0.5% hyperbaric bupivacaine alone and a 
combination of 3.0mL of 0.5% hyperbaric bupivacaine with 
2mg midazolam in spinal block. 
MATERIAL & METHOD  
Study design: A prospective double blinded case control study 
Study location & period: This study was conducted at Pravara 
Rural Hospital of Pravara Institute of Medical Sciences over a 
period of one year from Jan 2015 to Jan 2016 .  
Ethical approval: Approval from institutional ethical 
committee and written informed consent from patients were 
obtained prior to study.  
Inclusion criteria: 100 patients (ASA class I and II), aged 18 to 
55 years, undergoing elective infra-umbilical surgeries were 
included in this prospective double blinded case control study.  
Exclusion criteria: Patients not will ing for regional anesthesia, 
with a known contraindication, sensitivity to study drugs, 
having psychiatric disorders, pregnancy or using any drug that 
modifies pain perception were excluded from the study. 
Pre-medication: It was done with tab. Alprazolam 0.5 mg and 
tab. Ranitidine 150 mg orally the previous night for patients in 
both the groups and were advised to be nil  orally from 10 pm. 
All  patients were explained about the visual numeric scale 
(VNS) of pain assessment. On the day of surgery intravenous 
access was secured with 18-gauge venous cannula and 
preloading with 10 ml/ kg of lactated Ringer’s solution was 
done.  
Sampling method: The patients were randomly allocated into 
two groups through computer generated randomization.  
Group I:   Patients were administered 0.5% hyperbaric 
Bupivacaine (3 ml) + 0.9% Normal saline (0.4 ml) intrathecally. 
Group 2- patients were administered 0.5% hyperbaric 
Bupivacaine (3 ml) + 2mg preservative free Midazolam (0.4 ml) 
intrathecally. 
Method: Patient and the anesthesiologist who performed 
spinal block and made observations to the solution 
administered. The study solution was prepared by an 
anesthesiologist not involved in the administration of spinal 
anesthesia. A lumbar subarachnoid block was performed 
under strict aseptic precautions with patient in left lateral 
position, with a pil low under the head on a flat table. The L3-4 
inter-space was used for lumbar tap after local skin infi ltration 
with inj. 2% Xylocaine (2 ml). Sab arachnoid block was given 
using 26 Gauge Quincke needle through midline approach. 
After obtaining clear flow of CSF, drug was injected slowly 
using 5ml syringe, after negative aspiration for blood. Supine 
position was given to patients immediately after drug 
administration. The time of injection of the drug was recorded 
as 0 minute.  
During surgery, all  patients were given oxygen at 2L/min via 
nasal cannula and intravenous Ringers lactate solution for 
maintenance. Electrocardiography, pulse rate, NIBP, 
respiratory rate and SpO2 were monitored continuously and 
charting done every 5mins ti l l  first 1 hr and then every 15mins 
ti l l  surgery lasted and post operatively and every 15mins for 
2hrs. Sensory and motor block were assessed at 5, 10, and 15 
minutes after spinal anesthesia and then every 15 minutes 
during operation and until  1 h of recovery period by pin-prick 
testing bilaterally along the midclavicular l ine using a 26-gauge 
hypodermic needle. The umbilicus was considered as T10 
dermatomal level. Time taken for sensory block to reach level 
T10 after spinal anesthesia was recorded. Time taken to reach 
highest level and time for two segmental recession was also 
noted.  
Motor block was assessed using a 6-point modified Bromage 
scale (MBS) (1 = complete motor block; 2 = almost complete 
block, the patient is able to move feet only; 3 = partial motor 
block, where patient is able to flex the knees but unable to 
raise the leg; 4 = detectable weakness of hip flexion, where 
patient is able to raise the leg but is unable to maintain it; 5 = 
no detectable weakness of hip flexion; 6 = no weakness at 
all)[14]. Time of onset and duration of motor blockade was 
noted for all  the patients. Any complication or adverse effects 
were noted and managed accordingly. Inj. Ephedrine 5 mg 
intravenously in increments and rapid infusion of intravenous 
fluids was given to maintain mean arterial blood pressure 
within 20% of baseline. Drop in pulse rate below 50/min was 
considered bradycardia and managed with injection Atropine 
0.6mg intravenously. Inj. Ondansetron 4mg intravenously was 
given for Nausea & vomiting. Shivering was treated with warm 
drapes and warm intravenous fluids. Patients were shifted to 
the postoperative ward and observed til l  the first 
administration of analgesic (Inj. Diclofenac sodium 1.5mg/kg 
intramuscularly was given at the VNS score of 5 or on patients 
demand). Time for voiding post operatively was noted to 
assess the recovery of autonomic (sympathetic) activity, at the 
first successful trial of voiding. Patients were followed till  
discharge for delayed complications l ike urinary retention, 
transient neurological symptoms, post-dural puncture 
headache. 
Statistical analysis: All data were entered into a proforma in 
excel sheet for SPSS and subjected to statistical analysis. 
Student’s t test and One-way analysis of variance (ANOVA) 
was used for normally distributed parametric data. Repeated 
variables were analyzed with repeated measure of one-way 
ANOVA. Post hoc multiple comparison test was done using the 
Tukey-Kramer method. Statistical analysis was performed with 
statistical software (Statistical Package for Social Science 
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[SPSS] version 19.0 for Windows, SPSS, Inc.). A P value < 0.05 
was considered statistically significant.  
RESULTS 
The mean age in Group I was 35.94 ± 12.08 years with a 
minimum age of 18 years and maximum age of 55   years.   The 
mean   age   group   in Group   II was 36.1 ± 12.32 years with a 
minimum age of 18 years and maximum age of 55 years. The 
age difference between the groups is not statistically 
significant. Majority of cases in both groups were males - 58% 
in Group I and 56% in Group II were male patients. The mean 
duration of surgery was 105.98 ± 23.86 minutes in Group I, 
112.46 ±29.60 minutes in Group II. No significant statistical 
difference was found between the two groups with respect to 
age, sex of the patients and duration of surgery (p > 0.05).  
Table No. 1. Demographic Profile and Duration of surgery 
 Group I Group II P value 
Mean age (years) 35.94 36.1 0.8169 
Sex (m/f) 29/21 28/22 0.8399 
Duration of surgery (mins) 105.98 112.46 0.2311 
 
 
Figure 1. Age Distribution 
 
Figure 2. Sex Distribution 
Majority of patients (28%) in Group I underwent lower l imb 
surgery followed by lower abdominal and gynaecology 
surgeries. Majority of patients (28%) in Group II underwent 
urological surgery. The difference in surgica l procedure in both 
the groups was statistically not significant. (P=0.8043) 
 
Figure 3. Type of surgery 
 
Figure 4. Duration of surgery 
 
Figure 5. Mean Pulse rate variation 
Table 2. Type of surgery 
  Group I Group II TOTAL  
Type of Surgery No. % No. %  
Gynaecology 13 26 11 22 24 
Lower Abdominal 
Surgery 
13 26 13 26 26 
Lower Limb Surgery 14 28 12 24 26 
Urology 10 20 14 28 24 
TOTAL 50 100 50 100 100 
Changes in pulse rate (p=0.461), respiratory rate (p= 0.4137) 
and mean arterial pressure were comparable in both groups 
and was found to be statistically insignificant (p=0.4137). 
24%
30%
14%
32%
26%
24%
20%
30%
0%
5%
10%
15%
20%
25%
30%
35%
18- 25 26- 35 36-45 46 – 55
Age Distribution
Goup I Group II
0%
20%
40%
60%
Male Female
58%
42%
56%
44%
Sex Distribution
Group I Group II
26% 26% 28%
20%22%
26% 24%
28%
0%
10%
20%
30%
Gynaecology Lower
Abdominal
Surgery
Lower Limb
Surgery
Urology
Type of Surgery
Group I Group II
0%
20%
40%
60%
80%
90 – 120 
min
121-150
min
151-180
min
>180 min
74%
12% 12%
2%
74%
14% 8% 4%
Duration of Surgery
Group I Group II
65
70
75
80
85
Mean Pulse Rate
Group 1 Group 2
Page 28
Int J Clin and Biomed Res. 2017;3(1): 25-30. 
Abhishek et al.,   
  
 
Figure 6. Mean Arterial Pulse variation 
 
Figure 7. Respiratory Rate variation 
 
Figure 8. Mean duration for onset of sensory and motor 
blockade and time taken to reach T10 
 
Figure 9. Mean duration for two segmental regression, post 
operative analgesia and motor blockade. 
 
Figure 10. Highest level of sensory blockade achieved 
 
Figure 11. Duration of post operative analgesia 
Table 3. Sensory and Motor Block Characteristics. 
PARAMETER GROUP I GROUP II P Value 
Onset of sensory 
block 
3.98 + 1.42 2.64 + 0.74 <0.0001* 
Time taken to 
reach T10 
8.32 + 2.28 6.52 + 1.75 <0.0001* 
Onset of motor 
blockade 
4.74 + 1.14 3.68 + 0.58 <0.0001* 
Time for two 
segment 
regression 
132.82 + 13.59 162.24+18.3 <0.0001* 
Post- operative 
analgesia 
212.90 + 62.78 366.60 +50 <0.0001* 
Duration of 
motor blockade 
161.66 + 15.58 166.71+12.5 0.1272 
Data was presented as Mean ±SD, *Significant 
Table No.4: Comparison of time of onset of motor blockade.   
Onset of Motor Blockade 
 GROUP I GROUP II P value 
Time in 
Mins 
No. of 
patients 
% No. of 
patients 
% <0.0001 
3-4 18 36 49 98 
4-5 19 38 0 0 
>5 13 26 1 2 
Total 50 100 50 100 
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Figure 12. Intra operative complications. 
Intra-operative complications were observed more in group I 
compared to group II for bradycardia, hypotension + 
bradycardia and shivering. However, the differences were 
statistically insignificant for all  the complications. 
Table 6. Mean time for voiding. 
Time for voiding 
TIME in 
mins 
Group I Group II P value 
Minimum 146 195 0.1586 
Maximum 340 451 
Mean + SD 255.24 ± 57.04 272.02 ± 61.02 
The mean time for voiding was 272.02 ±61.02 minutes in 
group II as compared to 255.24 ±57.04 in group I and the 
difference was statistically not significant (p=0.1586). None of 
the patient had any complications in post-operative period in 
either group. 
DISCUSSION  
Onset of sensory blockade in present study was earlier in 
group II with mean time 2.64 minutes as compared to mean of 
3.96 minutes in group I, which concurs with studies by Vaswani 
et al [10], Nidhi et al [15], S. Sidiq et al [16] and Malavika Kulkarni 
et al [17] whereas Batra et al [6] observed no difference between 
the groups regarding onset of sensory block. Time to reach 
level of T-10 was less for group II with mean of 6.52 minutes in 
comparison with Group I with mean of 8.32 minutes whereas 
maximum level achieved is comparable in both groups. Nidhi 
et al [15] observed similar results in their studies, whereas 
according to Batra et al [6], S. Sidiq et al [16] and Malavika 
Kulkarni et al [17] no significant difference was found in both 
groups. Onset of motor blockade in our study was significantly 
quicker in group II with mean of 3.68 minutes compared to 
4.74 minutes in Group I, which is  similar to results observed by 
Vandana et al [18]. Duration of motor blockade in our study in 
Group I was 161.66 ± 15.58 minutes and 166.71 ± 12.46 
minutes in Group II which is statistically not significant (P value 
0.1272). Vandana et al [18] although found the difference 
significant with duration of motor blockade, none of the other 
authors have observed this in their studies. In our study mean 
time for two segmental sensory regression was 162.24 
minutes in Group II as compared to 132.82 minutes in Group I, 
which was statistically significant. MalviKa et al [17] observed 
significant difference between the midazolam group and 
normal saline group with regards to regression of sensory 
block. Nidhi et al [15] observed no significant difference between 
the groups, whereas Batra et al [4] observed that time to block 
regression and ambulation were faster with the control group. 
In our study, we found significant statistical difference in the 
mean time for rescue analgesia which was 366.60 minutes in 
Group II as compared to 212.90 minutes in Group I. The 
duration of analgesia in only 8% of patients was between 300-
400 minutes in Group I compared to 62% in Group II. For 24% 
of patients it was more than 400 minutes and in two patients 
it was more than 500 minutes in group II. This concurs with the 
studies of various other authors. Batra et al [6], Nidhi et al [15], 
Malvika et al [17], S.Sidiq et al [16] all  observed midazolam 
increases mean duration of analgesia. In our study no 
statistically significant deference was found in mean time for 
voiding which was 272.02 minutes in Group II as compared to 
255.24 minutes in Group I. This concurs with findings of Batra 
et al [6] and Kim et al [7] while Malvika et al [17] and S.Sidiq et al 
[16] did not mention it. In our study, hypotension was observed 
in 6% of patients (3 patients) in both the groups. Bradycardia 
was observed in 8% (4 patients) of Group I and in 4% (2 
patients) in Group II. Hypotension and bradycardia was 
observed in 6% of group I and 2% of Group II. These 
observations concur with the observations of Kim et al [7], 
Batra et al [6], Nidhi et al [15], Bharti et al [11], Valentine et al [13], 
Bhattacharya et al [9]. In present study, no statistically 
significant difference was found (p = 0.127) in mean the 
duration of maximum motor blockade, which was 161.66 ± 
15.58 with a range of 135 to 210 minutes in group I, and 166.71 
± 12.46 minutes with a range being 148 to 210 minutes in 
group II. This is consistent with the study of Batra et al [6]. Thus, 
midazolam has no effect on motor blockade and helps in early 
ambulation and day care surgery. All  patients were observed 
post operatively for 72 hours and observed for, urinary 
retention, transient neurological symptoms, and post dural 
puncture headache. None were reported or observed in the 
study group and concurs with the observations of Kim et al [7], 
Batra et al [6], Nidhi et al [15], Bharti et al [11], Valentine et a [13], 
Bhattacharya et al [9]. 
CONCLUSION  
It is evident from this study that minimal dose (2mg) of 
preservative free midazolam used as an adjuvant to 
bupivacaine intrathecally reduces onset time of sensory and 
motor blockade, also time taken to reach T-10. It also 
increases time taken for two segmental recession and mean 
duration of analgesia which offers advantage during the 
0%
5%
10%
Hypotension Bradycardia Hypotension
+ Bradycardia
Shivering
Intra operative 
complications
Group I Group II
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shifting and postoperative period giving adequate time for 
rescue analgesia. It does not alter the hemodynamic profile 
significantly which fulfi l ls the operative requirements, along 
with reduced incidence of nausea and vomiting. It shows no 
respiratory depressant effects unlike opioids. Thus, it offers a 
simple method with no adverse effects and hence definitely a 
better adjuvant to local anesthetics for infra umbilical 
surgeries. 
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